Filing analysis / Ownership / Hatfield Jeffrey S.

Top 10 companies

Hatfield Jeffrey S.		33
VTAE Vitae Pharmaceuticals Inactive		8
ATYR aTyr Pharma		6
VIR Vir Biotechnology		6
LRMR Larimar Therapeutics		5
VRDN Viridian Therapeutics		5
NVIVQ InVivo Therapeutics		3

Relative stock performance:

1M 3M 6M 1Y

Search information

Ownership

Filing Types

Hatfield Jeffrey S.

People

SEC filings

Source

By filing date (month)

Feb 2015

May 2024

By filing type

4		26
3		5
4/A		1
5		1

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.